missing translation for 'onlineSavingsMsg'
Få mere at vide
  1. Home
  2. Products
  3. Kemikalier
  4. Organiske forbindelser
  5. Benzenoider
  6. Benzen og substituerede derivater
  7. Fluorbenzener
  8. AGI-5198, MedChemExpress

AGI-5198, MedChemExpress

Artikelnummer. 16477426
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
10 mg
50 mg
100 mg
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Mængde
16477426 100 mg
16467458 10 mg
16413487 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 16477426 Leverandør Medchem Express Leverandørnr. HY18082

Please to purchase this item. Need a web account? Register with us today!

Denne vare kan ikke returneres. Se returpolicy

Beskrivelse

MedChemExpress AGI-5198 (IDH-C35) is a potent and selective mutant IDH1R132H inhibitor with an IC50 of 0.07 μM.

AGI-5198 (IDH-C35) is a potent and selective mutant IDH1R132H inhibitor with an IC50 of 0.07 μM.

Tekniske data

Kemisk navn eller materiale AGI-5198
CAS 1355326-35-0
Farve White
Renhedsgrad noter Research
Molekylær formel C27H31FN4O2
Mængde 100 mg
Synonym IDH-C35
Opløselighedsinformation DMF : ≥ 50 mg/mL (108.09 mM) ∣DMSO : 20.83 mg/mL (45.03 mM; Need ultrasonic)
SMIL FC1=CC=CC(N(C(C2=CC=CC=C2C)C(NC3CCCCC3)=O)C(CN4C=CN=C4C)=O)=C1
Molekylvægt (g/mol) 462.56
Formel vægt 462.56
Procent renhed 98.02%
Grad Research
Fysisk form Solid
Til brug med (applikation) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.